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Abstract
Objectives: Surgical margin status is a significant determinant of treatment outcome in oral 
cancer. Negative surgical margins can decrease the loco-regional recurrence by five-fold. The 
current standard of care of intraoperative clinical examination supplemented by histological frozen 
section, can result in a risk of positive margins from 5to 17 percent. In this study, we attempted to 
assess the utility of intraoperative optical coherence tomography (OCT) imaging with automated 
diagnostic algorithm to improve on the current method of clinical evaluation of surgical margin in 
oral cancer.
Materials and methods: We have used a modified handheld OCT device with automated 
algorithm based diagnostic platform for imaging. Intraoperatively, images of 125 sites were 
captured from multiple zones around the tumor of oral cancer patients (n = 14) and compared with 
the clinical and pathologic diagnosis.
Results: OCT showed sensitivity and specificity of 100%, equivalent to histological diagnosis 
(kappa, κ = 0.922), in detection of malignancy within tumor and tumor margin areas. In 
comparison, for dysplastic lesions, OCT-based detection showed a sensitivity of 92.5% and 
specificity of 68.8% and a moderate concordance with histopathology diagnosis (κ = 0.59). 
Additionally, the OCT scores could significantly differentiate squamous cell carcinoma (SCC) 
from dysplastic lesions (mild/moderate/severe; p ≤ 0.005) as well as the latter from the non-
dysplastic lesions (p ≤ 0.05).
Conclusion: The current challenges associated with clinical examination-based margin 
assessment could be improved with intra-operative OCT imaging. OCT is capable of identifying 
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microscopic tumor at the surgical margins and demonstrated the feasibility of mapping of field 
cancerization around the tumor.
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Introduction
Surgery is the primary treatment modality in management of oral cancers. Adequate surgical 
margin is one of the most important prognostic factors that determine disease outcome, with 
involved margin lowering the loco-regional control by five folds [1–3]. The standard surgical 
treatment involves tumor resection with a cuff of clinically normal tissue beyond the 
macroscopic tumor margin in an attempt to achieve microscopic tumor clearance. Given the 
need of a minimum of 5 mm pathological clearance and accounting for 30% tissue shrinkage 
due to formalin fixation, a 1 cm margin is the current standard adopted during surgical 
excision of oral cancer [4]. The intraoperative clinical evaluation may be supplemented by 
histological frozen section evaluation. However, this process is time consuming and the 
tissue processed cannot be revaluated by conventional histopathology. Even with frozen 
section evaluation, 5–17% of surgical resections can have positive surgical margins [2,5]. 
Several imaging modalities such as ultrasonography [6] and auto-fluorescence [7] have been 
attempted for the delineation of tumor margin, however none have gained widespread 
clinical use. Field cancerization refers to the lateral spread of tumors due to progressive 
transformation of cells adjacent to tumor rather than the spread and invasion of adjacent 
epithelium by preexisting tumor [8]. The presence of this field effect poses a significant risk 
for cancer recurrence and progression even after removal of primary tumors [9]. An intra-
operative, point-of-procedure diagnostic tool for the delineation of tumor margin and 
evaluation of the field cancerization effect is a clinical need, which may in turn lower the 
incidence of involved surgical margins and possibly improve disease outcome.
Optical coherence tomography (OCT) is a non-invasive modality with high-resolution 
microstructural imaging that maps the mucosal epithelium. The technology uses near 
infrared light and is widely used in the field of ophthalmology. OCT has been used in ex-
vivo margin evaluation in oral squamous cell carcinoma patients, which suggested that OCT-
based imaging could be used for tumor margin delineation [10]. We postulate that 
intraoperative OCT with automated diagnostic algorithm can improve accuracy of surgical 
margin delineation as compared to the current method of clinical and frozen section 
evaluation carried out during oral cancer excision surgery. Herein, we demonstrate the 
accuracy of intraoperative OCT with automated diagnostic algorithm to delineate the extent 
of field-cancerization during surgical excision of oral cavity cancers and its clinical efficacy 
to determine intra-operative tumor margin status.
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Materials and methods
Study population and design
The study was designed (Fig. 1) as a prospective pilot study that attempted to evaluate the 
feasibility of intra-operative OCT to delineate surgical margins in patients undergoing 
surgery for oral squamous cell carcinoma (OSCC). The study was approved by the 
institutional ethics committee (NHH/MEC-CL-2015–279) and subjects were recruited 
during a two-month period (September to October 2016) after obtaining written informed 
consent.
The subjects reporting to Head and Neck Oncology service, Mazumdar Shaw Medical 
Center, Narayana Health, Bangalore, India with newly diagnosed OSCC were accrued for 
the study. The inclusion criteria were (i) subjects who were > 18-year-old (ii) 
histopathologically confirmed OSCC, and (iii) who consented to the study protocol. The 
exclusion criteria were (i) previous history of OSCC, (ii) subjects who have undergone 
previous anti-cancer therapy other than biopsy for the index tumor (iii) mouth opening less 
than 3 cm. The demographics, clinical and pathological details are summarized in Table 1.
After induction of anesthesia, the operating surgeon clinically evaluated the lesion and 
demarcated the intended surgical margins using an indelible marking pen, which is at least 1 
cm away from the tumor induration. OCT images were captured intraoperatively from five 
different zones as shown in Fig. 1b. These zones constituted regions within tumor (Zone 1), 
tumor margin (Zone 2), surgical margin (Zone 3; 1cm from the clinical tumor margin), more 
than 1 cm away from surgical margin (Zone 4; > 2 cm from the clinical tumor margin), and 
contralateral side mucosa (Zone 5). Separate images were obtained from at least two 
different quadrants within each of the zones. Punch biopsies were performed from each of 
the imaged sites for histopathological correlation. The biopsy specimens were reported by 
pathologist according to WHO criteria [11,12]. The pathologist was blinded from the 
clinical and OCT diagnosis. Histopathology diagnosis was considered as the gold standard 
(reference standard) for comparison with clinical (current standard of care) and OCT 
diagnosis (index test). The extent of surgical margin was determined by clinical evaluation 
by the surgeon, assisted by frozen-section when indicated. The OCT imaging data was 
blinded to the operating surgeon. Every field which underwent interrogation by clinical, 
OCT imaging and histopathology was designated as normal, oral potentially malignant 
lesion (OPML) or malignant lesion.
OCT device and algorithm-based OCT score
The in-vivo OCT images were acquired using SD-OCT system (Supplementary Fig. 1A) 
[13] with the prototype 1-D scanning long probe (Supplementary Fig. 1B) [13]. The SD-
OCT system using center wavelength of 930 nm has an axial resolution of 7.0 μm and lateral 
resolution of 15.0 μm. Using a 20 kHz, 1024-point CCD line-scan camera on the 
spectrometer detection arm, an imaging speed of 1.2 kHz was achieved (2 images per 
second) and image analysis takes 5–10 s for diagnosis depending on the size of the image 
field of view. A long rigid one pitch GRIN rod was used in this study to relay light from the 
proximal portion of the probe to the patient’s tissue [13]. A MATLAB image processing 
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algorithm adopted from a previous study [14] was utilized to differentiate healthy and 
abnormal oral mucosa. Images were processed by the OCT system using an algorithm 
reported by our group earlier [13]. The OCT based algorithm assigned a neoplastic score, 
which stratified the lesion as non-dysplastic (−0.0918 to - 0.1280), dysplastic (−0.0780 to 
−0.0918) or malignant (−0.0580 to −0.0780) [13].
Statistical analysis
Sample size estimation: The minimum sample size was calculated for the diagnostic 
study [15]. Considering the alpha value of < 0.05 and power of 80% the minimum sample 
size required for the study is 78 sites [15]. We expected a drop out of 20% due to poor image 
quality and difficulty in imaging. The total sample size required is 94 sites in 14 patients (7 
images per patient, not including contralateral normal). Therefore 14 patients were recruited 
in the study and 125 images were recorded.
Descriptive statistics were used to summarize details of patient demography, clinical 
features, and pathological diagnosis. Continuous variables were reported using median and 
interquartile range. Kolmogorv-Smirnov test was performed to assess the normal distribution 
of OCT scores and all statistical comparison between multiple groups were assessed by one-
way-analysis of variance (ANOVA) using Kruskal-Wallis test. McNemar test was used to 
compare the proportions. The agreement between histopathology with OCT and visual/
palpation diagnosis were examined using Kappa statistics [16,17]. P value < 0.05 (2 sided) is 
considered as significant. The sensitivity and specificity of OCT based diagnosis were 
calculated. All statistical analyses were done using Medcalc 14.8.1
Results
Clinical details of study population
A total of 125 images were captured from 14 patients, who were diagnosed with OSCC. The 
mean age of the patients was 55 years (range from 39 to 78). Twenty-eight percentage (n = 
4) of patients were female and 72% (n = 10) were male with 93% (n = 13) of all patients 
having the history of tobacco use. The sites of the tumor were primarily buccal mucosa 
(44%, n = 6) with the other sites being alveolus (21%, n = 3), gingivo-buccal sulcus (14%, n 
= 2), tongue (14%, n = 2) and retro-molar-trigone (7%, n = 1). Majority of tumors were T4 
(50%, n = 7) and T2 (36%, n = 5) lesions. The images (n = 120) captured included tumor (n 
= 13), tumor margins (n = 34), surgical margins (n = 35), > 1 cm surgical margin (n = 25) 
and the contralateral normal (n = 13) (Table 1).
OCT based diagnosis showed high correlation with histology
Among the 125 images, 120 were included in the analysis. Five images were excluded due 
to poor image quality. The details and distribution of the images based on the zones are 
provided in the study consort chart (Fig. 2). Histological evaluation (Supplementary Fig. 2) 
indicated that most of the sites were diagnosed as mild dysplasia (46%; n = 56); the others 
being SCC (20%; n = 24), moderate dysplasia (15%; n = 19) and severe dysplasia (4%; n = 
5). Thirteen percent were non-dysplastic lesions (n = 16), wherein there was a clear 
demarcation of epithelium and connective tissue, however this structured architecture was 
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lost in SCC (Fig. 3). OCT diagnosis of neoplastic/dysplastic areas was comparable to 
histology in the tumor and tumor margin (zones 1–5) with excellent concordance (k = 0.83, 
CI = 0.73–0.93) (Fig. 4). Comparison between the OCT and histological diagnosis indicated 
that the OCT scores correlated with severity of the disease (Fig. 5). Kruskal-Wallis test 
showed significant difference among the groups; the OCT scores showed a range within 
each cohort and could differentiate SCC from non-dysplastic and dysplastic lesions (mild/
moderate/severe; p ≤ 0.05) and dysplastic from non-dysplastic lesions (p ≤ 0.005).
A patient-wise analysis of the histology and OCT diagnosis showed that out of 14 patients, 
57% (n = 8) showed SCC (11 fields) and/or severe dysplasia (5 fields) in tumor margins 
(Zone 2–4), all of which are detected by OCT accurately. In these eight patients, 38% (n = 3) 
of patients showed close margin (tumor in < 5 mm) in other sites after microscopic 
examination of completely excised tumor. Forty-three percentage (n = 6) showed no 
malignancy or severe dysplasia by OCT and histology (incisional biopsy) with ex-vivo 
microscopic examination also showing negative margins (> 0.5 cm).
Delineation of the malignant field by OCT
Tumor (Zone 1) and Tumor margins (Zone 2): Attempts were made to delineate the 
malignant and/or dysplastic field in these zones by OCT and visual examination. The results 
of which correlated with histopathology findings. Out of 47 sites (tumor, n = 13; tumor 
margin, n = 34), 49% (n = 23) were diagnosed as SCC, while 51% (n = 24) sites were 
dysplastic/non-dysplastic by histology. In comparison to the gold standard, OCT-based 
assessment showed a sensitivity and specificity of 100% (Table 2) in detection of malignant 
fields (SCC was considered as test positive and dysplastic/non-dysplastic lesion as test 
negative for efficacy evaluation). OCT score demonstrated excellent concordance with 
histology (κ = 0.92, CI = 0.82–1) in assessment of neoplastic/dysplastic areas. Clinical 
examination showed 100% specificity and 56.5% sensitivity (CI = 34.5–76.8), with poor 
concordance with histopathology (κ = 0.26, CI = 0.14–0.37). The low sensitivity was due to 
the under-diagnosis of malignant sites (n = 10) in the tumor margin (zone 2). McNeamer test 
shows significant difference between visual method (standard of care) and histopathology 
diagnosis (p = 0.0002).
Delineation of the dysplastic field by OCT
Surgical margins and contralateral sites (Zone 2 to Zone 5): Out of 80 
histologically diagnosed dysplastic lesions in the margins and the contralateral sites, 92% (n 
= 74) were accurately diagnosed by OCT, while out of 16 non-dysplastic lesions 
(histopathological diagnosis), 69% (n = 11) sites were accurately diagnosed. For analysis, 
dysplastic lesions were considered as test positive and non-dysplastic lesions as test 
negative. The sensitivity and specificity for detection of dysplastic lesion by OCT were 
92.5% (CI = 84.4–97.2) and 68.8% (11/16, CI = 49.3–89) respectively with moderate 
agreement with histopathology diagnosis (κ = 0.59; CI = 0.38–0.81). McNeamer test 
showed no significant difference between histopathology and OCT based diagnosis. 
Classification into grades showed that out of 80 lesions, 6% (n = 5), 24% (n = 19) and 70% 
(n = 56) were diagnosed as severe, moderate and mild dysplastic lesions respectively by 
histology. Among them, all severe and moderate dysplastic lesions (high-risk) [18] were 
Sunny et al. Page 5
Oral Oncol. Author manuscript; available in PMC 2020 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
diagnosed as dysplasia by OCT. Eighty nine percentage (n = 50/56) of mild dysplasia were 
detected by OCT, while 11% of sites were designated as normal. Clinical examination 
diagnosed 24% (n = 19) of the dysplastic lesions as OPML.
Zone-wise assessment of field cancerization
Further, individual comparisons were carried out within each site of imaging around the 
tumor to document the accuracy of diagnosis of OCT in mapping the field of cancerization 
(Fig. 3).
Zone 1- Tumor (n = 13): OCT as well as clinical examination diagnosed all the sites in 
the tumor zone as malignant lesions accurately.
Zone 2-Tumor margin (n = 34): Histological evaluation diagnosed 30% of the biopsies 
as malignant (n = 10). OCT detected all malignant sites precisely, however, clinical 
diagnosis identified these sites as normal. A comparison of the dysplastic sites (64%, n = 
22/34) in the tumor margin indicated that OCT diagnosed all of them accurately, while 32% 
(n = 11/34) were diagnosed as OPML and 68% (n = 23/34) as normal by clinical method. 
Among the images, 6% were non-dysplastic lesions (n = 2/34), which were accurately 
diagnosed by visual method but over-diagnosed by OCT imaging as dysplastic. The 
agreement between OCT and histology diagnosis in this zone was 0.876 (CI = 0.721–1).
Zone 3-Surgical margin, (n = 35): In the surgical margins, only 3% (1/35) was 
designated malignant by histology, which were accurately diagnosed as malignant by OCT 
but were considered normal by clinical examination. Majority of the sites were diagnosed as 
dysplastic lesion by histopathology (80%, 28/35), out of which 89% (n = 25/28) were 
diagnosed as dysplastic and 10% (n = 3/28) as normal by OCT. Clinical examination 
identified 21% (n = 6/28) and 79% (22/28) of the sites as OPML and normal respectively. 
Among the non-dysplastic lesions identified by histopathology (17%, n = 6/35), 67% (n = 
4/6) were diagnosed accurately by OCT, while the remaining 33% (n = 2/6) were diagnosed 
as dysplastic. Clinical examination diagnosed all the non-dysplastic sites as normal. Kappa 
statistics indicated a good agreement between OCT and histology diagnosis (k = 0.60, CI = 
0.27–0.92).
Zone 4- > 1 cm from surgical margin (n = 25): Beyond 1 cm from the surgical 
margin, 84% (n = 21/25) of the sites were dysplastic lesions by histopathology; out of these 
96% (n = 20/21) were detected by OCT, while only 4% were detected (1/21) visually as 
OPML. Among the non-dysplastic sites (16%, n = 4/25), 75% (n = 3/4) were diagnosed 
accurately by OCT. All of them were deemed normal by visual diagnosis, while OCT over 
diagnosed 25% (n = 1/4) as dysplastic lesions. The agreement between histology and OCT 
diagnosis was 0.70 (CI = 0.31–1).
Zone 5-Contralateral mucosa (n = 13): 69% (n = 9) of contralateral sites were 
diagnosed dysplastic by histopathology. Of which, OCT detected 78% (n = 7/9) as dysplasia, 
while 11% (n = 1/9) were clinically diagnosed as OPML. All the non-dysplastic sites were 
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diagnosed accurately by OCT and clinical examination. The agreement between the OCT 
and histology diagnosis was 0.83 (0.34–1).
Discussion
Accurate demarcation of the surgical margin is critical for improving outcome of patients 
undergoing surgery for oral cancer. Surgical margin with 5 mm of histologically uninvolved 
mucosa is mandated by the current clinical guidelines [19]. Close (< 3mm) and positive 
margins propound poor prognosis [1,2]. The current practice of surgery guided by clinical 
examination by the surgeons and supplemented by frozen section histopathology is unable to 
offer consistent evaluation of surgical margins [2,5]. The sensitivity and specificity of frozen 
section in comparison to conventional histology is 72.7% and 93.9% respectively for oral 
cancer [20]. Given the need to improve the margin status post surgical resection, intra-
operative imaging methods that reflect the ‘microscopic’ changes in the tumor-surrounding 
field could be of immense clinical utility. This study presents the first in-vivo, intraoperative, 
OCT-based real time imaging for delineation of tumor margin in patients undergoing surgery 
for oral cancer. The results suggest that OCT based diagnosis is equivalent to histology in 
detection of malignant/dysplastic fields with significant improvement over clinical 
examination, the current standard of care.
Imaging methods have been the major area of focus in intra-operative margin assessment in 
many cancers [21,22]. OCT has been proven effective in margin delineation of breast 
[21,22], skin [23] and vulva [24] malignancies reporting high sensitivity (90–100%) and 
specificity (80–92%). OCT combined with reflectance confocal microscopy showed 100% 
sensitivity in detection and depth assessment of basal cell carcinoma [25]. Label-free 
reflectance hyperspectral imaging with machine learning based classification showed 90% 
accuracy in tumor margin detection [26]. In oral cancer, OCT has been used for margin 
evaluation ex-vivo, confirming the efficacy of the imaging technique [10]. In this study, for 
the first time, OCT imaging with algorithm-based prediction was investigated intra-
operatively and showed significant concordance (k = 0.92) with histological diagnosis of 
malignancies (100% specificity/sensitivity). The data also demonstrated that significant 
areas of clinically normal mucosa can harbor malignant lesions (n = 11). These occult 
malignant lesions could be detected accurately using intra-operative OCT imaging. The 
excellent concordance of OCT score and histology obtained suggested the possibility of 
using OCT as a surrogate for histopathology during intraoperative evaluation. Further, in an 
effort to improve the feasibility, the OCT device used in the study has been adapted and 
made portable to be used in the operation theatre (Supplementary Fig. 1A). The probe was 
also modified with long rigid rode with short ends that helped to take the image of different 
sites of oral cavity easily (Supplementary Fig. 1B). The accuracy along with its improved 
accessibility and portability designate this OCT device as a significant point of care tool for 
surgical margin delineation.
In an early detection setting, multiple imaging- based systems including algorithm-based 
dual model image analysis, autofluorescence, high-resolution microendoscopy (HRME), 
reflectance spectroscopy has showed good concordance with clinical detection of OPML 
[27,28]. The sensitivity of OCT in detecting dysplastic lesions around the tumor margins in 
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this study was significantly higher than clinical examination, with all the high-risk lesions 
[18] being detected by the OCT with statistically different scores. Significantly, all the 
OPMLs detected by clinical examination were diagnosed as dysplastic by OCT and 
subsequently by histology. However, low specificity (68%) in diagnosis of mild dysplastic 
lesions indicated that efficacy of OCT based diagnosis in differentiating between grades of 
dysplasia needs further research. Nevertheless, in the context of its utility in surgical margin 
demarcation, its accurate diagnosis of malignant and high-risk dysplastic lesions (moderate 
and severe dysplastic lesion) will have significant clinical utility [29].
A significant finding of this study was the ability of OCT based imaging to identify all 
malignant fields (n = 10) in tumor margin area and in the surgical margins (n = 1), which 
were clinically deemed normal. Evaluation of the OCT images of these sites shows loss of 
normal stratification of mucosa, while the histology shows discontinuous basement 
membrane and dysplastic sheets of cells in the stroma (Fig. 3). Microscopic examination, 
after total excision of tumor, showed submucosal extension of tumor in three patients. 
Additionally, one malignant site detected by OCT from outside surgical margin was also 
proven to be squamous cell carcinoma. The high-resolution visualization of deep structural 
morphologies achieved by OCT imaging in combination with the automated image analysis 
and scoring, improved the efficacy and reduced the subjectivity in the diagnosis. The 
accuracy in the diagnosis of sub-epithelial tumors indicated the potential of OCT for tumor 
margin delineation. Utilization of intra-operative OCT imaging in such tumors will enable 
more precise mapping of the tumor and tailoring the surgical margins.
As majority of oral cancer is caused by high-risk habits such as smoking, chewing of 
tobacco/areca nut and consumption of alcohol, the entire oral cavity mucosa can harbor 
dysplastic mucosa by the process of field cancerization [30–32]. The clinical significance of 
dysplastic lesions in the surgical margin is controversial, demonstrating both positive [33] 
and no correlation [34] with local recurrence. Field cancerization is an indicator of the extent 
of disease spread and increases the risk of disease recurrence and development of second 
primary tumors [31]. The alterations in the dysplastic field have been previously demarcated 
primarily in skin cancers by active tele thermography (ATT), narrow band imaging (NBI), 
HD-OCT and hyperspectral imaging enabling the detection of subclinical disease [35–38]. 
The field of cancerization in oral cancer has been interrogated by fluorescence imaging, dye-
based techniques and biomarker-based studies [6,7,39], that showed capability to detect sub-
clinical neoplastic fields, although a systematic mapping was not carried out. The mapping 
of the field around the tumor, as carried out in this study by OCT, indicated the presence of 
high-risk dysplastic sites in the surgical margin, at distances of over 1 cm from the margin 
(71%; n = 17/24; Supplementary Fig. 2). The high accuracy in delineating high-risk 
dysplastic sites at different distances from the tumor, suggested the feasibility of this non-
invasive method to precisely map the field of cancerization. Field cancerization correlates to 
risk habits of the patients [31], however in this study this correlation could not be 
investigated as majority of the patients (n = 13/14) had risk habits. Nevertheless, the high 
incidence of dysplasia in the field (including the contralateral sites (69%)) detected in this 
study can be attributed to this high prevalence of risk habits.
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Apart from evaluation of mucosal extent of tumor, assessment of deeper invasion of tumor is 
important to achieve three-dimensional tumor clearance during surgery. This study 
highlights the potential of OCT based imaging to delineate the mucosal and sub-mucosal 
extension of the tumor. However, considering the significance of deep margins as a 
prognosticator, the major limitation of the OCT, as applied in this study, was its inability to 
interrogate tissue over 2 mm depth. This is a limitation of OCT at its current stage of 
development.
Conclusion
Non-invasive and point-of-care methods that provide accurate diagnosis of the margin status 
intra-operatively are an invaluable adjunct to improving the efficacy of margin assessment. 
The present study demonstrates the accuracy of OCT-based imaging in identifying close 
margins that were undetected by visual examination; the detection of malignant clones in the 
surgical margins of patients that was deemed normal by clinical examination, was a 
significant finding. Additionally, the good concordance of OCT with histopathology for both 
malignant and high-risk lesions and its portability suggests a potential clinical application to 
map field cancerization around the tumor. Larger validation studies that include correlation 
with treatment outcome are mandatory prior to adaptation of the technology in the clinical 
practice, nevertheless, this study definitely outlines the significance and feasibility of OCT 
based surgical margin delineation.
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Fig. 1. 
Study design. Clinical image (A) and schematic representation (B) of a patient with 
carcinoma of maxilla indicating the zones and the imaging sites. The tumor (T, Zone 1) is 
indicated along with the black outline representing the tumor margin (Zone 2). The imaging 
sites (A1 & B1) within zone 1 are also indicated. Blue outline represents the surgical-
excision margin (Zone 3, imaging sites: A2 & B2), which is 1 cm away from clinical tumor 
margins and the yellow outline (Zone 4, imaging sites: A3 & B3) represents the region 1 cm 
away from the surgical margins (2 cm from the clinical tumor margin). OCT images using 
portable device (C) were captured intra-operatively after the surgeon marked the incision 
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line around the tumor. OCT images of 4 zones with OCT diagnosis and histology diagnosis 
in brackets is represented (D). Incisional biopsy was done with a 5 mm diameter punch at 
the point from which the OCT imaging was carried out (E). Histopathology diagnosis was 
compared to OCT and visual/palpation diagnosis. (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. 
Study consort chart. Details of the patients, the total number of images captured and the 
distribution of patients’ images in different zones according to histopathology and OCT 
diagnosis are provided. M=malignant, D=Dysplastic, ND=Non-Dysplastic, SCC- Squamous 
cell carcinoma.
Sunny et al. Page 14
Oral Oncol. Author manuscript; available in PMC 2020 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
Representative Clinical, OCT and Histology images of patients. (A1) Clinical image of a 
case of SCC of buccal mucosa; a clinically normal site (white circle) was chosen for OCT 
imaging and was diagnosed as malignancy by OCT (A2). The histology (A3-100×; inset 
400×) shows loss of continuity of basement membrane with dysplastic epithelial islands in 
connective tissue suggesting squamous cell carcinoma. (B1) Clinical image of a patient with 
SCC of tongue; a clinically normal site outside the surgical margin (white circle) was 
imaged by OCT image (B2) and was diagnosed as dysplasia. Histopathology (100×) 
diagnosis was severe epithelial dysplasia (B3). (C1) Clinical image of a case of SCC of 
buccal mucosa, a clinically normal (white circle) outside the surgical margin was diagnosed 
by OCT (C2) and histology (C3) (100×) as non-dysplastic.
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Fig. 4. 
Comparative diagnosis of all images captured from different zones of all patients. Each 
block (brown dotted lines) represents each patient (n = 14). The central grey area represents 
the tumor (zone 1) with black outline representing the margin (Zone 2), blue (Zone 3) and 
yellow outline (Zone 4) representing the surgical margin and > 1 cm from surgical margin 
respectively. Each small circle represents the captured sites, with the colors indicating the 
comparative diagnosis. The circles around the outside of the black outline (zone 5) 
represents imaged sites from contralateral sites. Red, yellow and white represent concordant 
diagnosis of SCC, dysplasia and non-dysplasia, while blue and green colored small circles 
represent false negative and false positive respectively in diagnosis of dysplasia. (P = 
Patient) (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.)
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Fig. 5. 
Distribution of OCT score according to histology diagnosis. Box whisker plot indicating the 
OCT score of individual sites classified according to histopathology diagnosis. Kruskal 
wallis test show significant variance within the groups (p < 0.005) and no significant 
difference between moderate and severe dysplasia. The data shows median and interquartile 
range (**p < 0.005, * p < 0.05).
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Table 2:
Sensitivity, specificity (with 95% confidence interval) and accuracy of OCT and visual diagnosis in detection 
of malignancy and dysplasia in the different zones (zone 1–5).
Method Sensitivity Specificity Accuracy
OCT – malignancy (Zone 1&2) 100 (85.2–100) 100 (85.8–100) 100
Visual – Malignancy (Zone 1 & 2) 56.5 (34.5–76.9) 100 (96.3–100) 78.7
OCT- Dysplasia (zone 2–5) 92.5 (84.4–97.2) 68.8 (41.3–88.9) 88.5
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